Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BCL2L11
REST API REST API
Homo sapiens
BCL2L11 is differentially expressed in 327 experiments: 121 organism parts: mammary gland, bone marrow, ... (119 more);, 188 disease states: normal, breast carcinoma, ... (186 more);, 106 cell types 426 cell lines 54 compound treatments and 90 other conditions.
Synonyms BimEL, BIM, BOD, BimL
Orthologs Bcl2l11 (Mus musculus)   Q2YDF0_BOVIN (Bos taurus)   Bcl2l11 (Rattus norvegicus)   NP_001027511.1 (Xenopus laevis)   BCL2L11 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term endomembrane system, cytosol, plasma membrane, microtubule binding, protein binding, apoptosis, cytoplasm, spermatogenesis, activation of caspase activity, male gonad development, positive regulation of apoptosis, intracellular membrane-bounded organelle, mitochondrial outer membrane, regulation of organ growth, developmental pigmentation, induction of apoptosis, cell-matrix adhesion, microtubule, peripheral to membrane of membrane fraction, post-embryonic development, positive regulation of cell cycle, regulation of developmental pigmentation, mitochondrion, regulation of apoptosis, myeloid cell homeostasis, activation of pro-apoptotic gene products, in utero embryonic development, kidney development, induction of apoptosis by intracellular signals, mammary gland development, spleen development, B cell homeostasis, ear development, leukocyte homeostasis, T cell homeostasis, induction of apoptosis by extracellular signals, post-embryonic organ morphogenesis, positive regulation of release of cytochrome c from mitochondria, nerve growth factor receptor signaling pathway, positive regulation of neuron apoptosis, thymus development, odontogenesis of dentine-containing tooth, tube formation, lymphocyte homeostasis, B cell apoptosis, cellular process regulating host cell cycle in response to virus, positive regulation of protein homooligomerization, BIM-BCL-2 complex, BIM-BCL-xl complex
InterPro Term Apoptosis_Bim_N, Bcl-x_interacting, Bcl-2-like_11
UniProt Accession Q8WXB2, C9J417, O43521, Q6JTU4, E9PAM9
Search EB-eye ENSG00000153094
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (25 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-2450, E-MTAB-62, ... (41 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-20081, E-GEOD-19639, E-GEOD-3529, E-GEOD-5823
SNU16
2
E-MTAB-37, E-GEOD-15460
CCRFCEM
2
E-MTAB-37, E-GEOD-24147
LNCaP
2
E-GEOD-14464, E-GEOD-14990
MCF7
2
E-GEOD-5258, E-MTAB-37
MDA468
2
E-MEXP-440, E-MTAB-62
420 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-GEOD-3920, E-GEOD-20677, E-GEOD-21750, ... (51 experiments)

Factor Value U/D Experiments
human embryonic stem cell
3
E-GEOD-20033, E-GEOD-18265, E-GEOD-18147
monocyte
1
3
E-MEXP-2019, E-GEOD-11755, E-GEOD-7307, E-GEOD-22373
embryonic stem cell
2
E-MEXP-930, E-GEOD-26672
endothelial cell
1
2
E-GEOD-3920, E-GEOD-3998, E-GEOD-19240
stromal cell
1
2
E-GEOD-1460, E-MEXP-2034, E-GEOD-10797
basal cell
1
E-GEOD-3998
100 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-TABM-15, E-MEXP-2280, ... (67 experiments)

Factor Value U/D Experiments
acute promyelocytic leukemia
2
E-GEOD-96, E-GEOD-1729
cervical carcinoma
2
E-GEOD-5823, E-MTAB-37
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
acute lymphoblastic leukemia
2
E-MTAB-37, E-MTAB-62
breast cancer
2
E-MTAB-62, E-GEOD-22544
chronic lymphocytic leukemia
2
E-GEOD-2466, E-GEOD-6691
182 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-4668, E-GEOD-5258, E-GEOD-5741, E-TABM-782, ... (33 experiments)

Factor Value U/D Experiments
none
4
9
E-MEXP-1230, E-MEXP-1958, E-GEOD-412, E-GEOD-2803, E-MEXP-1601, ... (13 experiments)
lipopolysaccharide
1
2
E-MEXP-1958, E-TABM-868, E-GEOD-3720
cooked broccoli
1
E-MEXP-1372
endotoxin
1
E-GEOD-2322
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
unknown
1
E-GEOD-7307
48 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-TABM-325, E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, ... (10 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-22513, E-GEOD-4619, ... (8 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-2171, E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-5999, E-GEOD-20033, E-MEXP-2359, E-GEOD-4667, E-MEXP-2283, ... (6 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-22544, E-GEOD-3325, E-GEOD-22148, E-MEXP-2280, ... (7 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (9 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-GEOD-2466, E-TABM-868, E-GEOD-20115, ... (14 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-GEOD-21612, E-MEXP-2657, E-GEOD-20540, ... (18 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-GEOD-2466, E-MEXP-2069, ... (37 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-6802

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-22056

Ki67 ihc
studied in E-GEOD-21653

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-22152, E-GEOD-21750, E-GEOD-1657, E-MEXP-1403 ... (5 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-1880, E-GEOD-19445, E-GEOD-19246 ... (5 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10797, E-GEOD-10896

RNAi
studied in E-MEXP-101, E-GEOD-3697, E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

Sample type
studied in E-TABM-783

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-19743, E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276, E-GEOD-2748

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-GEOD-19246, E-GEOD-15799, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4922

Tumor size
studied in E-GEOD-8167

Vehicle
studied in E-GEOD-5258

Processing time: 0.318 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM